GURUFOCUS.COM » STOCK LIST » Asia » China » SZSE » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Shiller PE Ratio
Switch to:

China National Accord Medicines (SZSE:000028) Shiller PE Ratio

: 15.52 (As of Today)
View and export this data going back to 1993. Start your Free Trial

As of today (2023-03-25), China National Accord Medicines's current share price is ¥44.40. China National Accord Medicines's E10 for the quarter that ended in Sep. 2022 was ¥2.86. China National Accord Medicines's Shiller PE Ratio for today is 15.52.

The historical rank and industry rank for China National Accord Medicines's Shiller PE Ratio or its related term are showing as below:

SZSE:000028' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.1   Med: 39.75   Max: 81.4
Current: 15.62

During the past years, China National Accord Medicines's highest Shiller PE Ratio was 81.40. The lowest was 10.10. And the median was 39.75.

SZSE:000028's Shiller PE Ratio is ranked better than
69.23% of 39 companies
in the Medical Distribution industry
Industry Median: 20.96 vs SZSE:000028: 15.62

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

China National Accord Medicines's adjusted earnings per share data for the three months ended in Sep. 2022 was ¥0.880. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥2.86 for the trailing ten years ended in Sep. 2022.

Shiller PE for Stocks: The True Measure of Stock Valuation


China National Accord Medicines Shiller PE Ratio Historical Data

The historical data trend for China National Accord Medicines's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.75 20.90 19.86 18.31 13.64

China National Accord Medicines Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.06 13.64 12.32 10.63 10.45

Competitive Comparison

For the Medical Distribution subindustry, China National Accord Medicines's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

China National Accord Medicines Shiller PE Ratio Distribution

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Shiller PE Ratio falls in comparison to its industry or sector. The grey bar indicates the Shiller PE Ratio's extreme value range as defined by GuruFocus.



China National Accord Medicines Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

China National Accord Medicines's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=44.40/2.86
=15.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China National Accord Medicines's E10 for the quarter that ended in Sep. 2022 is calculated as:

For example, China National Accord Medicines's adjusted earnings per share data for the three months ended in Sep. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=0.88/115.3387*115.3387
=0.880

Current CPI (Sep. 2022) = 115.3387.

China National Accord Medicines Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 0.411 95.237 0.498
201303 0.499 96.372 0.597
201306 0.406 95.984 0.488
201309 0.472 97.332 0.559
201312 0.433 97.624 0.512
201403 0.582 98.600 0.681
201406 0.491 98.200 0.577
201409 0.438 98.900 0.511
201412 0.403 99.000 0.470
201503 0.543 99.900 0.627
201506 0.525 99.500 0.609
201509 0.515 100.500 0.591
201512 0.607 100.600 0.696
201603 0.600 102.200 0.677
201606 0.958 101.400 1.090
201609 0.591 102.400 0.666
201612 0.651 102.600 0.732
201703 0.640 103.200 0.715
201706 0.660 103.100 0.738
201709 0.577 104.100 0.639
201712 0.594 104.500 0.656
201803 0.680 105.300 0.745
201806 0.820 104.900 0.902
201809 0.666 106.600 0.721
201812 0.665 106.500 0.720
201903 0.700 107.700 0.750
201906 0.820 107.700 0.878
201909 0.720 109.800 0.756
201912 0.720 111.200 0.747
202003 0.580 112.300 0.596
202006 0.920 110.400 0.961
202009 0.830 111.700 0.857
202012 0.940 111.500 0.972
202103 0.770 112.662 0.788
202106 0.960 111.769 0.991
202109 0.780 112.215 0.802
202112 0.610 113.108 0.622
202203 0.590 114.335 0.595
202206 0.980 114.558 0.987
202209 0.880 115.339 0.880

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


China National Accord Medicines  (SZSE:000028) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


China National Accord Medicines Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

China National Accord Medicines logo
Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines